CONTACT US
Home > Inhibitors/Agonists> > Calcifediol monohydrate
63283-36-3-Calcifediol monohydrate Calcifediol monohydrate

Calcifediol monohydrate

For research use only. Not for therapeutic Use.

  • CAT Number: I004385
  • CAS Number: 63283-36-3
  • Molecular Formula: C27H46O3
  • Molecular Weight: 418.65
  • Purity: ≥95%
Inquiry Now
Related Small Molecules: Hirsuteine     S-22153     Tert-butyl 4-(3-(trifluoromethyl)benzoyl)piperidine-1-carboxylate    

Calcifediol monohydrate（Cat No.:I004385） has the effect of treating osteoporosis, the main circulating metabolite of vitamin D3, and is a competitive inhibitor with a Ki value of 3.9 μM. Calcidiol, the major circulating metabolite of vitamin D3, is a competitive inhibitor with an apparent Ki of 3.9 μM.


Catalog Number I004385
CAS Number 63283-36-3
Synonyms

(1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol;hydrate

Molecular Formula C27H46O3
Purity ≥95%
Target VD/VDR
Solubility 10 mM in DMSO
Storage Store at -20°C
IUPAC Name (1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol;hydrate
InChI InChI=1S/C27H44O2.H2O/c1-19-10-13-23(28)18-22(19)12-11-21-9-7-17-27(5)24(14-15-25(21)27)20(2)8-6-16-26(3,4)29;/h11-12,20,23-25,28-29H,1,6-10,13-18H2,2-5H3;1H2/b21-11+,22-12-;/t20-,23+,24-,25+,27-;/m1./s1
InChIKey WRLFSJXJGJBFJQ-WPUCQFJDSA-N
SMILES CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C.O
Reference

<p style=/line-height:25px/>
<br>[1]. Kleinman LM, Letteri JM, Asad SN, Ellis KJ, Cohn SH. Effects of calcifediol on calcified tissue in uremia. Arch Intern Med. 1978 May 15;138 Spec No:864-5.
<br>[2]. Recker R, Schoenfeld P, Letteri J, Slatopolsky E, Goldsmith R, Brickman A. The efficacy of calcifediol in renal osteodystrophy. Arch Intern Med. 1978 May 15;138 Spec No:857-63.
<br>[3]. Teitelbaum SL, Bone JM, Stein PM, Gilden JJ, Bates M, Boisseau VC, Avioli LV. Calcifediol in chronic renal insufficiency. Skeletal response. JAMA. 1976 Jan 12;235(2):164-7.
<br>[4]. Teitelbaum SL. Calcifediol (25-hydroxyvitamin D3) in the treatment of uremic bone disease. Ann Intern Med. 1981 Mar;94(3):404-5.
<br>[5]. Langman CB, Mazur AT, Baron R, Norman ME. 25-hydroxyvitamin D3 (calcifediol) therapy of juvenile renal osteodystrophy: beneficial effect on linear growth velocity. J Pediatr. 1982 May;100(5):815-20.
<br>[6]. BY J. W. BLUNT, YOKO TANAKA, AND H. F. DELUCA. THE BIOLOGICAL ACTIVITY OF 25-HYDROXYCHOLECALCIFEROL,A METABOLITE OF VITAMIN D3. PNAS December 1, 1968 vol. 61 no. 4 1503-1506
</p>

Request a Quote